InsiderFlow

Christopher Durant Turner

NUVL

Christopher Durant Turner serves as officer: Chief Medical Officer at Nuvalent, Inc. (NUVL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$1.44M

Net Position

Net Seller

$1.44M

Companies Traded

1

NUVL

Active Period

Jan 2026

2 total trades

Most Recent

Sell NUVL

Jan 7, 2026 · $721.3K

Christopher Durant Turner's Insider Trading at Nuvalent, Inc. (NUVL)

Buys

0 · $0.00

Sells

2 · $1.44M

Total Shares Bought

0

Total Shares Sold

14,834

NUVL Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jan 7, 2026Sell7,417$97.25$721.3K61,676
Jan 5, 2026Sell7,417$97.25$721.3K0